The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data

C.G. Urzua-Traslavina , N.J. Latino , M. Galotti , N.I. Cherny , S.F. Oosting , E.G.E. de Vries , R.S.N. Fehrmann
{"title":"The ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) visualisation: picturing the evidence of clinical benefit of clinical trial data","authors":"C.G. Urzua-Traslavina ,&nbsp;N.J. Latino ,&nbsp;M. Galotti ,&nbsp;N.I. Cherny ,&nbsp;S.F. Oosting ,&nbsp;E.G.E. de Vries ,&nbsp;R.S.N. Fehrmann","doi":"10.1016/j.esmorw.2025.100171","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Choosing the right cancer treatment is crucial for patients and health care professionals, while health care systems must allocate resources efficiently. The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) assists decision making by assessing the clinical benefit of anticancer medications. ESMO developed and field-tested a visualisation of the ESMO-MCBS scores to increase its user-friendliness and effectiveness.</div></div><div><h3>Methods</h3><div>An expert panel iteratively designed and internally reviewed a prototype of the visualisation, then refined it through field-testing. A survey was conducted concurrently with the field-testing to evaluate the understandability of the visualisation. Field-testing materials and survey questions were made accessible to the public on the ESMO website and promoted at the ESMO Congress 2019 through ESMO social media platforms. The insights gathered from all the feedback were instrumental in refining the design. Subsequently, a conclusive survey was deployed during the ESMO Congress 2023 to assess the final version of the visualisation.</div></div><div><h3>Results</h3><div>A two-panel visualisation was developed to reflect the steps of the ESMO-MCBS scoring procedure. Field-testing included visualisations for 121 studies, each based on their ESMO-MCBS scores. Feedback from the survey (<em>n</em> = 56 experts) indicated that oncology-related professions and statisticians, as well as respondents with previous knowledge of the ESMO-MCBS, showed a sufficient understanding of the visualisations while indicating areas to improve. Incorporating the survey’s feedback, the revised visualisations were then integrated into the publicly available ESMO-MCBS Scorecards, and a final survey (<em>n</em> = 118 experts) was conducted to evaluate these revisions. More than 80% of the respondents reported the visualisation to be accessible and effective at communicating the score.</div></div><div><h3>Conclusions</h3><div>The visualisations offer a visual understanding of the ESMO-MCBS scores by enhancing user-friendliness and understandability.</div></div>","PeriodicalId":100491,"journal":{"name":"ESMO Real World Data and Digital Oncology","volume":"9 ","pages":"Article 100171"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Real World Data and Digital Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949820125000608","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Choosing the right cancer treatment is crucial for patients and health care professionals, while health care systems must allocate resources efficiently. The European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) assists decision making by assessing the clinical benefit of anticancer medications. ESMO developed and field-tested a visualisation of the ESMO-MCBS scores to increase its user-friendliness and effectiveness.

Methods

An expert panel iteratively designed and internally reviewed a prototype of the visualisation, then refined it through field-testing. A survey was conducted concurrently with the field-testing to evaluate the understandability of the visualisation. Field-testing materials and survey questions were made accessible to the public on the ESMO website and promoted at the ESMO Congress 2019 through ESMO social media platforms. The insights gathered from all the feedback were instrumental in refining the design. Subsequently, a conclusive survey was deployed during the ESMO Congress 2023 to assess the final version of the visualisation.

Results

A two-panel visualisation was developed to reflect the steps of the ESMO-MCBS scoring procedure. Field-testing included visualisations for 121 studies, each based on their ESMO-MCBS scores. Feedback from the survey (n = 56 experts) indicated that oncology-related professions and statisticians, as well as respondents with previous knowledge of the ESMO-MCBS, showed a sufficient understanding of the visualisations while indicating areas to improve. Incorporating the survey’s feedback, the revised visualisations were then integrated into the publicly available ESMO-MCBS Scorecards, and a final survey (n = 118 experts) was conducted to evaluate these revisions. More than 80% of the respondents reported the visualisation to be accessible and effective at communicating the score.

Conclusions

The visualisations offer a visual understanding of the ESMO-MCBS scores by enhancing user-friendliness and understandability.
esmo -临床获益量表(ESMO-MCBS)可视化:描绘临床试验数据的临床获益证据
选择正确的癌症治疗对患者和卫生保健专业人员至关重要,而卫生保健系统必须有效地分配资源。欧洲肿瘤医学学会临床获益等级量表(ESMO-MCBS)通过评估抗癌药物的临床获益来协助决策。ESMO开发并现场测试了ESMO- mcbs评分的可视化,以提高其用户友好性和有效性。方法由专家小组迭代设计并内部评审可视化原型,然后通过现场测试对其进行完善。在现场测试的同时进行了一项调查,以评估可视化的可理解性。现场测试材料和调查问题在ESMO网站上向公众开放,并通过ESMO社交媒体平台在2019年ESMO大会上进行宣传。从所有反馈中收集到的见解有助于完善设计。随后,在2023年ESMO大会期间部署了一项结论性调查,以评估可视化的最终版本。结果采用双面板可视化方法反映ESMO-MCBS评分步骤。现场测试包括121项研究的可视化,每项研究都基于他们的ESMO-MCBS分数。来自调查的反馈(n = 56位专家)表明,肿瘤学相关专业人员和统计学家,以及之前了解ESMO-MCBS的受访者,在指出需要改进的领域时,对可视化表现出了充分的理解。结合调查的反馈,修订后的可视化结果被整合到公开的ESMO-MCBS记分卡中,并进行最终调查(118名专家)来评估这些修订。超过80%的受访者表示,可视化在传达分数方面是可访问的和有效的。结论可视化方法通过增强用户友好性和可理解性,为ESMO-MCBS评分提供了直观的理解。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信